Skip to content

AWARE trial

AWARE: Elective Adhesiolysis vs. a Wait-and-see Policy to Prevent Recurrences after Conservative Treatment of Adhesive Small Bowel Obstruction - AWARE trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON57650
Enrollment
260
Registered
2024-12-16
Start date
2025-11-03
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adhesive small bowel obstruction Small bowel obstruction

Interventions

The intervention of investigation is elective adhesiolysis. Adhesiolysis is an abdominal procedure in which all adhesions are cut, and adhesion prevention applied to reduce the risk of adhesion refo

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria:- Adult patients aged 18 years and older who have recently recovered from aSBO  by conservative management for small bowel obstruction. - Patients who have previously been operated (high a prior risk of adhesions)  are required to have no signs of other causes of bowel obstruction on imaging  studies (CT-scan). - Patients with no previous operation in history (low a prior risk of  adhesions) are required to have typical signs for aSBO on imaging studies  (abrupt change of bowel calibre, closed loop, or signs of torsion on vessels in  the mesentery on CT-scan).

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded  from participation in this study: - Patient who are unfit for operation for surgical, anesthesiological or  medical reasons as determined by multidisciplinary team assessment or  pre-operative screening- Patient who has undergone surgery for previous episodes of aSBO in the past six months- Patient who has undergone previous episodes of aSBO in the past six months - Patients with active malignancy, reducing life expectancy - Pregnancy

Design outcomes

Primary

MeasureTime frame
Primary outcome is recurrence at 2 years, defined as readmission for obstructive systems with aetiology of adhesions confirmed by CT.

Secondary

MeasureTime frame
We hypothesize a 50% reduction in recurrence in the intervention arm. Secondary outcomes are morbidity from surgery, health-related quality of life (EQ5D), healthcare costs and societal costs (iMCQ and iPCQ)

Countries

Belgium, Netherlands

Contacts

Public ContactR.P.G. Ten Broek

Radboud Universitair Medisch Centrum

Richard.tenBroek@radboudumc.nl0636304310

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Apr 17, 2026